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Abstract
The purpose of the present study was to examine whether lack of skeletal
muscle peroxisome proliferator-activated receptor gamma coactivator 1 alpha
(PGC-1a) affects the switch in substrate utilization from a fed to fasted state
and the fasting-induced pyruvate dehydrogenase (PDH) regulation in skeletal
muscle. Skeletal muscle-specific PGC-1a knockout (MKO) mice and floxed lit-
termate controls were fed or fasted for 24 h. Fasting reduced PDHa activity,
increased phosphorylation of all four known sites on PDH-E1a and increased
pyruvate dehydrogenase kinase (PDK4) and sirtuin 3 (SIRT3) protein levels,
but did not alter total acetylation of PDH-E1a. Lack of muscle PGC-1a did
not affect the switch from glucose to fat oxidation in the transition from the
fed to fasted state, but was associated with lower and higher respiratory
exchange ratio (RER) in the fed and fasted state, respectively. PGC-1a MKO
mice had lower skeletal muscle PDH-E1a, PDK1, 2, 4, and pyruvate dehydro-
genase phosphatase (PDP1) protein content than controls, but this did not
prevent the fasting-induced increase in PDH-E1a phosphorylation in PGC-1a
MKO mice. However, lack of skeletal muscle PGC-1a reduced SIRT3 protein
content, increased total lysine PDH-E1a acetylation in the fed state, and pre-
vented a fasting-induced increase in SIRT3 protein. In conclusion, skeletal
muscle PGC-1a is required for fasting-induced upregulation of skeletal muscle
SIRT3 and maintaining high fat oxidation in the fasted state, but is dispens-
able for preserving the capability to switch substrate during the transition
from the fed to the fasted state and for fasting-induced PDH regulation in
skeletal muscle.
Introduction
Skeletal muscle plays a major role in lipid and carbohy-
drate (CHO) utilization and is instrumental in maintain-
ing metabolic flexibility with various metabolic challenges.
Specifically fasting robustly prompts the protection of
CHO stores through a coordinated decrease in skeletal
muscle glucose oxidation and a switch toward fat oxida-
tion. Pyruvate dehydrogenase (PDH) is thought to be a
key element in such regulation of substrate utilization
(Randle et al. 1994). Hence, the pyruvate dehydrogenase
complex controls the access of CHO to the TCA cycle by
irreversibly converting pyruvate to acetyl CoA thereby
bridging glycolysis and oxidative substrate utilization
(Harris et al. 2002). However, the detailed regulation of
PDH during energy deprivation is not fully understood
and merits further investigation.
The main regulation of PDH activity is thought to be
through inhibitory phosphorylation by PDH kinases
(PDKs) and activating dephosphorylation by PDH phos-
phatases (PDPs) at four known serine residues on the cat-
alytic subunit PDH-E1a (PDH) (Patel and Korotchkina
2001; Roche et al. 2001; Harris et al. 2002; Kiilerich et al.
2010). In addition, recent studies point toward other
important posttranslational modifications as the mito-
chondrially located deacetylase Sirtuin 3 (SIRT3) has been
reported to regulate the acetylation state of PDH-E1a and
thus the activity of PDH (Jing et al. 2013; Fan et al. 2014;
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Ozden et al. 2014). Previous studies have demonstrated
that fasting reduces the activity of PDH in the active form
(PDHa activity) (Sugden et al. 2000; Spriet et al. 2004),
increases PDHSer293 and PDHSer300 phosphorylation (Kii-
lerich et al. 2010), and increases PDH-E1a acetylation as
well as PDK4 mRNA (Wu et al. 1999; Sugden et al. 2000;
Pilegaard et al. 2003) and protein (Sugden et al. 2000;
Spriet et al. 2004; Kiilerich et al. 2010) in rodent skeletal
muscle. Furthermore, fasting has been reported to elicit a
muscle-type-dependent regulation of PDK activity and
PDK4 expression in rat skeletal muscle (Sugden et al.
2000). However, the factors determining this are not
resolved.
Peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (PGC-1a), first discovered and iden-
tified as a PPARc-binding protein in brown adipose tis-
sue (Puigserver et al. 1998), is a transcriptional
coactivator that has been established to be an important
regulator of mitochondrial biogenesis. Hence, muscle-
specific PGC-1a overexpression mice have been shown to
have increased content of oxidative proteins and con-
versely whole-body PGC-1a knockout and muscle-speci-
fic PGC-1a knockout mice to have lowered content of
oxidative proteins in skeletal muscle (Lin et al. 2004;
Leick et al. 2008; Geng et al. 2010). Furthermore, mus-
cle-specific PGC-1a overexpression mice have been
shown to exhibit lower respiratory exchange ratio (RER)
during treadmill running (Calvo et al. 2008; Wong et al.
2015). This may be due to the enhanced skeletal muscle
oxidative capacity of these mice (Lin et al. 2002), but
may also be related to metabolic flexibility and regula-
tion of substrate use. In accordance, the level of skeletal
muscle PDH-E1a protein content has been shown to fol-
low differences in the level of muscle PGC-1a in mice
(Kiilerich et al. 2010) and PGC-1a to regulate PDK4
expression in mouse skeletal muscle (Wende et al. 2005;
Calvo et al. 2008; Kiilerich et al. 2010). In addition, the
fasting-induced downregulation of PDHa activity was
blunted in PGC-1a KO mice (Kiilerich et al. 2010) sup-
porting that PGC-1a plays a role in PDH-mediated
metabolic regulation during fasting. However, the impact
of PGC-1a on the switch from CHO to fat utilization
during the transition from the fed to the fasted state,
and on the level of fat utilization in the fasted state
as well as the associated regulation of PDH in skeletal
muscle is not fully resolved.
Therefore, the aim of the present study was to exam-
ine whether lack of muscle PGC-1a (1) affects the time
course of the switch in substrate utilization during
the transition from a fed to fasted state, (2) affects
regulation of fasting-induced changes in PDHa activity,
PDH phosphorylation, and PDH acetylation in skeletal
muscle.
Methods
Animals
Generation of PGC-1a MKO mice used in the present
study was carried out as described previously (Lin et al.
2004; Geng et al. 2010). The mice were genotyped using
PCR-based muscle and tail genotyping as previously
described (Leick et al. 2008) and the genotype was con-
firmed based on determination of PGC-1a mRNA in
muscle tissue after euthanization. Animals were kept on a
12:12-h light–dark cycle at 22°C with ad libitum access to
water and chow diet (Altromin 1314F, Brogaarden, Lynge,
Denmark) until the intervention of the experiment. All
experiments were approved by the Danish Animal Experi-
ments Inspectorate and complied to the European Con-
vention for the protection of vertebrate animals used for
experiments and other scientific purposes (Council of
Europe no. 123. Strasbourg, France 1985).
Fasting procedure
At 3 months of age, female mice were individually housed
for 3 days and subsequently allocated to either a fed
group (FED), which maintained ad libitum access to both
food and water, or a fasted group (FAST), for which the
food was removed at 6 AM and only water was available
for the following 24 h. As we have previously not
observed PGC-1a-dependent gender differences in meta-
bolic parameters (Leick et al. 2008), female mice were
used in the present study due to availability. Fed and
fasted mice were euthanized by cervical dislocation at the
end of the 24 h intervention period and quadriceps mus-
cles were rapidly excised and snap frozen in liquid nitro-
gen. Quadriceps muscle was chosen to ensure sufficient
amount of tissue for the analyses. Trunk blood was
obtained in EDTA containing tubes and plasma was
obtained after centrifugation. Both muscle and plasma
were stored at 80°C. A subset of mice (n = 8–10; indi-
vidually housed) were acclimatized to the environment of
the cabinets in a TSE Phenomaster unit (TSE Systems,
Bad Hamburg, Germany) for 3 days with a constant set-
ting of 22°C, 30% humidity, and a 12:12-h light–dark
cycle for determination of activity level and indirect
calorimetry measurements followed by data collection
(laser beam breaks, respiratory exchange ratio [RER]) for
24 h with ad libitum access to food and water followed
by 24 h of fasting with only access to water.
Plasma analyses
Plasma free fatty acid concentrations were measured using
a NEFA-HR kit according to the manufacturer’s
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guidelines (WAKO Diagnostics GmbH, Germany). Plasma
glucose and lactate were measured fluorometrically as
described previously (Lowry and Passonneau 1972).
Muscle analyses
Whole quadriceps muscles were crushed in liquid nitro-
gen to achieve tissue homogeneity. For measurements of
muscle glucose, lactate, and glucose-6-phosphate (G-6-P),
10–15 mg of crushed muscle tissue was extracted in
perchloric acid (PCA), neutralized to a pH of 7–8 and
measured as described above for plasma. Muscle glycogen
was determined fluorometrically as glycosyl units after
hydrolyzing 10–15 mg wet weight muscle samples by boil-
ing for 2 h in 1 mol/L HCl as described previously
(Lowry and Passonneau 1972).
Immunoblotting
Crushed muscle samples (25–30 mg) were homogenized
in lysis buffer (10% glycerol, 20 mmol/L Na-pyropho-
sphate, 150 mmol/L NaCl, 50 mmol/L HEPES, 1% NP-
40, 20 mmol/L b-glycerophosphate, 10 mmol/L NaF,
1 mmol/L EDTA, 1 mmol/L EGTA, 20 lg/ml aprotinin,
10 lg/ml leupeptin, 2 mmol/L Na3VO4, 3 mmol/L benza-
midine, and deacetylase inhibitors [nicotinamide,
1 mmol/L, and sodium butyrate, 5 mmol/L], pH 7.5)
using a Tissue Lyser II (Qiagen, Germany). Protein con-
centration in each of the samples was determined using
the bicinchoninic acid method (Thermo Fischer Scien-
tific) and protein concentration was adjusted with sample
buffer to a concentration of 1 lg/ll. Protein phosphoryla-
tion and protein content were determined by SDS-PAGE
using hand-casted gels and western blotting. PVDF mem-
branes were incubated in optimized primary antibody
solutions overnight at 4°C for determination of AMPKa2
(1:20,000), PDK4 (1:4000), and PDH-E1a protein
(1:1000), PDH-E1aSer293(1:1000), PDH-E1aSer300 (1:1000),
and PDH-E1aSer295phosphorylation (1:1000) (all kindly
provided by Professor Grahame Hardie, University of
Dundee, Scotland), hexokinase (HK) II protein (1:1000),
AMPKThr172phosphorylation (1:1000), total lysine acetyla-
tion (1:1000) (#2867, #2535 and #9441, respectively, Cell
Signaling Technologies, Danvers, MA), acetyl-CoA
carboxylase (ACC)Ser212 phosphorylation (1:1000), and
PDH-E1aSer232 phosphorylation (1:4000) (07-303 and
#AP1063, respectively, EMD Millipore, Bedford), TBC1D4
(1:20.000), PDK1 (1:1000), and OXPHOS proteins
(1:1000) (ab24469, ab90444, and ab110413, respectively,
Abcam, Cambridge, UK), PDK2 protein (1:1000)
(ST1643, CalBioChem, Bedford), PDP1 protein (1:1000)
(Sigma-Aldrich, St. Louis), and GLUT4 protein (1:1000)
(PAI-1065, ABR, Connecticut). Species-specific
horseradish peroxidase-conjugated immunoglobulin sec-
ondary antibodies (DAKO, Denmark) were used for incu-
bation the following day. ACC2 protein was detected
using streptavidin (1:2000) (Dako, Glostrup, Denmark).
Protein bands were subsequently visualized using an
ImageQuant LAS 4000 imaging system and quantified
with ImageQuant TL 8.1 software (GE Healthcare,
Freiburg, Germany).
Immunoprecipitation and PDH-E1a
acetylation
A total of 200 lg protein from lysate was immunopre-
cipitated for the determination of global PDH-E1a
acetylation. Briefly, the lysate was added to PBS-rinsed
protein G agarose beads (EMD Millipore, Bedford) in a
50:50 solution with PBS buffer containing 0.5% Triton
X with 2 lg of PDH-E1a antibody. The samples were
rotated end over end at 4°C overnight and on the sub-
sequent day the beads were washed, sample buffer was
added, and the samples were heated at 96°C for 3 min.
The beads were spun down to avoid transfer and lysate
loaded on a hand-casted gel for SDS-page and western
blotting as described above. For each sample, acetylated
protein was normalized to the amount of precipitated
PDH-E1a protein content determined by western
blotting.
PDHa activity
PDHa activity was determined after homogenizing 10–
15 mg of wet weight muscle tissue and snap-freezing the
homogenate in liquid nitrogen as described previously
(Cederblad et al. 1990; Constantin-Teodosiu et al. 1991;
Putman et al. 1993) with modifications (Pilegaard et al.
2006) and PDHa activity was normalized to creatine
content in each muscle sample to correct for nonmuscle
tissue in the sample as previously described (St Amand
et al. 2000).
Statistics
All values are expressed as means  standard error. A
two-way ANOVA was applied to test the effects of geno-
type and intervention. If data passed the prerequisites of
normality and equal variance and a main effect was
detected, a Student–Newman–Keuls test was applied as a
post hoc test to locate specific differences in group means
(McHugh 2011). For single grouped data, a Student’s
t-test was used to test if a difference was present. Signifi-
cance was accepted at Ps < 0.05. The statistical tests were
performed using Sigmaplot 13.0 (Systat, San Jose, CA,
USA).
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Results
Metabolic markers
OXPHOS basal protein content was lower (P < 0.05) in
PGC-1a MKO than control mice. There were no signifi-
cant differences in basal HKII, GLUT4, and TBC1D4 pro-
tein between genotypes (Fig. 1).
Indirect calorimetry and locomotor activity
RER was overall lower (P < 0.05) and activity higher
(P < 0.05) in PGC-1a MKO than control mice at night in
the fed state, while RER was overall higher (P < 0.05)
and activity lower (P < 0.05) in PGC-1a MKO than con-
trol mice at night in the fasted state (Fig. 2A and B). In
the final hour of the dark, fed period (5–6 AM), RER was
lower (P < 0.05) and in the last hour of the dark, fasting
period higher (P < 0.05) in PGC-1a MKO than control
mice (Fig. 2C).
Plasma glucose and NEFA
The plasma free fatty acid concentration increased
(P < 0.05) and the plasma glucose concentration decreased
(P < 0.05) in both PGC-1a MKO and control mice with
fasting. There were no differences in either plasma NEFA
or plasma glucose levels between genotypes (Table 1).
Muscle metabolites
Muscle glucose and glycogen concentrations decreased
(P < 0.05) in both PGC-1a MKO and control mice in
response to fasting with no difference between genotypes.
G-6-P decreased (P < 0.05) with fasting in PGC-1a MKO
and tended to be lower (0.1 ≤ P ≤ 0.05) in PGC-1a
MKO mice than control mice (Table 2).
AMPK and ACC
There were no differences in either absolute (Fig. 3A) or
normalized AMPK phosphorylation or in AMPKa2
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protein in skeletal muscle with fasting or between geno-
types (Fig. 3B). There was a tendency for an increase
(0.05 ≤ P ≤ 0.1) in absolute ACC phosphorylation
(Fig. 3C) with fasting in control mice, while there was no
difference in normalized ACC phosphorylation with fast-
ing in control mice (Fig. 3D). Fasting increased
(P < 0.05) both absolute (Fig. 3C) and normalized ACC
phosphorylation (Fig. 3D) in skeletal muscle of PGC-1a
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MKO mice, while ACC2 protein was lower (P < 0.05) in
PGC-1a MKO than control mice in the fed state.
PDHa activity and PDH-E1a protein
PDHa activity decreased (P < 0.05) markedly in skeletal
muscle with 24 h of fasting in both PGC-1aMKO and con-
trol mice with no difference between genotypes (Fig. 4A).
PDH-E1a protein content increased (P < 0.05) in both
genotypes after 24 h of fasting relative to fed and PDH-E1a
protein was lower (P < 0.05) in PGC-1aMKO than control
mice in both the fed and fasted state (Fig. 4B).
PDH phosphorylation
PDHSer293, PDHSer300, PDHSer232, and PDHSer295 phos-
phorylation increased (P < 0.05) with 24 h of fasting,
regardless of genotype. PDHSer293 and PDHSer300 phos-
phorylation was lower (P < 0.05) in PGC-1a MKO than
control mice in the fasted state (Fig. 5A, C, E, G). When
normalized to PDH-E1a protein, phosphorylation sites
PDHSer293 and PDHSer300 increased (P < 0.05) to a similar
level with fasting in PGC-1a MKO and control mice,
while PDHSer232 overall was higher (P < 0.05) in PGC-1a
MKO than control mice and PDHSer295 tended to be
higher (0.05 ≤ P ≤ 0.1) in PGC-1a MKO than control
mice both in the fed state and after 24 h of fasting
(Fig. 5B, D, F, H).
PDK1, 2, 4, and PDP1
There was an overall tendency for lower (P < 0.05) skeletal
muscle PDK1 protein in PGC-1a MKO than control mice,
while PDP1 protein and PDK2 protein were lower
(P < 0.05) in PGC-1a MKO than control mice with no
effect of the fasting intervention (Fig. 6A–C). PDK4 pro-
tein increased (P < 0.05) in both genotypes after 24 h of
fasting and was lower (P < 0.05) in PGC-1a MKO than
control mice both in the fed and the fasted state (Fig. 6D).
SIRT3 and PDH acetylation
Skeletal muscle SIRT3 protein was lower (P < 0.05) in
PGC-1a MKO than control mice in the fed state and
increased (P < 0.05) after 24 h of fasting only in control
mice (Fig. 7A). PDH-E1a acetylation was higher
(P < 0.05) in PGC-1a MKO than control mice in the fed
state, but was not different between genotypes after 24 h
of fasting (Fig. 7B).
Discussion
The main findings of the present study are that lack of
muscle PGC-1a did not affect the switch from CHO to fat
utilization in the transition from the fed to the fasted
state, but was associated with higher CHO use in the
fasted state potentially influencing the ability to endure
Table 1. Plasma glucose and nonesterified fatty acids (NEFA) in fed (FED) and 24 h fasted (FAST) skeletal muscle-specific PGC-1a knockout
(MKO) and littermate-floxed control (control) mice.
FED FAST
Control MKO Control MKO
Glucose (mmol/L) 6.11  0.2 6.03  0.2 4.03  0.17* 4.24  0.22*
NEFA (mmol/L) 0.15  0.01 0.13  0.01 0.23  0.01* 0.25  0.02*
Values are given as mean  SE (n = 8–10).
*Significantly different from FED within given genotype (P < 0.05).
Table 2. Concentrations of skeletal muscle glucose, glucose-6-phosphate (G-6-P), and glycogen in fed (FED) and 24 h fasted (FAST) skeletal
muscle-specific PGC-1a knockout (MKO) and littermate-floxed control (control) mice.
FED FAST
Control MKO Control MKO
Glucose (mmol/kg) 0.84  0.06 0.77  0.06 0.47  0.04* 0.48  0.03*
G-6-P (mmol/kg) 2.37  0.17 2.20  0.11 1.97  0.35 1.40  0.18*
Glycogen (mmol/kg) 23.9  2.3 24.5  1.6 15.9  1.6* 13.0  1.5*
Values are given as mean  SE (n = 11).
*Significantly different from FED within given genotype (P < 0.05).
#Significantly different from control within given group (P < 0.05).
2017 | Vol. 5 | Iss. 7 | e13222
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prolonged starvation. Fasting-induced downregulation of
PDHa activity in skeletal muscle of control mice was asso-
ciated with increased phosphorylation of all four known
sites in PDH-E1a as well as with increased PDK4 and
SIRT3 protein without changes in total acetylation of
PDH-E1a. Lack of muscle PGC-1a reduced PDH-E1a,
PDK1, 2, 4, PDP1, and SIRT3 protein content as well as
increased total lysine PDH-E1a acetylation in the fed state.
Knockout of muscle PGC-1a did not influence the fasting-
induced increase in PDH-E1a phosphorylation, but pre-
vented the fasting-induced increase in SIRT3 protein,
while additional factors seem to override PGC-1a-medi-
ated regulation of PDH-E1a acetylation during fasting.
The observed switch in substrate utilization from CHO
to fat and the lower RER value during fasting than in the
fed state in the control mice are in accordance with
numerous previous studies (Kersten et al. 1999; Frier
et al. 2011; Jensen et al. 2013; Wueest et al. 2014)
demonstrating an experimental foundation for examining
the impact of skeletal muscle PGC-1a on the ability to
switch substrate during fasting. The present finding that
lack of skeletal muscle PGC-1a had no clear impact on
the time course of the change in RER during the switch
from the fed to the fasted state suggests that skeletal mus-
cle PGC-1a is not required for metabolic flexibility during
this transition. This is as such in accordance with the
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Figure 3. (A) AMPK Thr172 phosphorylation normalized to AMPKa2 protein content, (B) AMPKa2 protein content, (C) acetyl-CoA carboxylase
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fasted (FAST) skeletal muscle-specific PGC-1a knockout (MKO) and littermate floxed controls (control) mice. Values are given as mean  SE
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previous observation that lack of muscle PGC-1a did not
influence the fluctuations in RER over the course of 24 h
with access to food (Finley et al. 2012).
Because the activity level was higher in PGC-1a MKO
than control mice during the dark period in the fed state,
and increased activity is expected to enhance carbohydrate
utilization, the genotype difference in substrate oxidation
in the fed state does not seem to be related to activity dif-
ferences. Likewise, the differences in average activity levels
between genotypes in the fed state, and generally high
levels of activity in the fasted state, were not associated
with differences in RER values. That being said, differ-
ences in activity level cannot be completely excluded to
have an effect on the observed RER differences. Moreover,
the similar plasma glucose and NEFA concentrations as
well as similar muscle glycogen in fed PGC-1a MKO and
control mice indicate that the RER differences in the fed
state are not due to differences in substrate availability
between the genotypes.
The observation that PGC-1a MKO mice had higher
RER in the final phase of the fasted state than the control
mice indicates that lack of skeletal muscle PGC-1a
reduced fat oxidation in the fasted state, although this
effect cannot be excluded to be driven by differences in
locomotor activity. The finding that the PGC-1a MKO
mice overall were less physically active than the controls
during the last 12 h of fasting shows that the higher car-
bohydrate oxidation was not due to increased activity
level in the PGC-1a MKO mice relative to control. Fur-
thermore, the similar plasma glucose and NEFA concen-
trations as well as muscle glycogen level in the two
genotypes suggests that differences in substrate availability
did not elicit the difference in substrate utilization. How-
ever, while the decrease in plasma glucose and the
increase in plasma NEFA concentration were independent
of genotype, the finding that the absolute decrease in
mean muscle glycogen was 44% greater in PGC-1a MKO
than control mice supports the higher reliance on carbo-
hydrates in the PGC-1a MKO than the control mice.
Based on the previous observation that muscle-specific
PGC-1a overexpression resulted in reduced glycogen
phosphorylase content and phosphorylation (Wende et al.
2007) with concomitantly reduced glycogen use during
exercise, it may be suggested that the higher glycogen use
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Figure 4. (A) PDHa activity and (B) PDH-E1a protein in quadriceps muscle from fed (FED) and 24 h fasted (FAST) skeletal muscle-specific PGC-
1a knockout (MKO) and littermate-floxed controls (control) mice. Values are given as mean  SE (n = 11). Protein levels are given in arbitrary
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Figure 5. (A) PDH Ser293 phosphorylation, (B) PDH Ser293 phosphorylation normalized to PDH-E1a protein content, (C) PDH Ser300
phosphorylation, (D) PDH Ser300 phosphorylation normalized to PDH-E1a protein content, (E) PDH Ser232 phosphorylation, (F) PDH Ser232
phosphorylation normalized to PDH-E1a protein content, (G) PDH Ser295 phosphorylation, (H) PDH Ser295 phosphorylation normalized to PDH-
E1a protein content in quadriceps muscle from fed (FED) and 24 h fasted (FAST) skeletal muscle-specific PGC-1a knockout (MKO) and
littermate-floxed controls (control) mice. Values are given as mean  SE (n = 11). Protein and phosphorylation (phos) levels are given in
arbitrary units (AU). *Significantly different from FED within given genotype (P < 0.05). #Significantly different from control within given group
(P < 0.05).
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in PGC-1a MKO mice in the present study is caused by
an elevated glycogen phosphorylase activity. Furthermore,
the observed decrease in skeletal muscle G-6-P with fast-
ing in PGC-1a MKO mice only supports that the gly-
colytic flux and glucose oxidation were higher in PGC-1a
MKO than control mice. In addition, the reduced fat oxi-
dation in PGC-1a MKO mice relative to control mice in
the fasted state may imply that low skeletal muscle PGC-
1a content is associated with impaired carbohydrate spar-
ing during food deprivation. The present observation that
TBC1D4 protein content was similar in the two genotypes
may suggest that the higher carbohydrate oxidation in
PGC-1a MKO mice was not due to differences in GLUT4
translocation to the plasma membrane, although it cannot
be ruled out that other factors in the translocation pro-
cess may be affected by lack of PGC-1a.
The present finding that SIRT3 protein increased with
24 h of fasting in control mice is in agreement with pre-
vious findings (Palacios et al. 2009; Hirschey et al. 2010;
Caton et al. 2011). Previous studies suggest that ROS
balance is impaired when PGC-1a is lacking (St-Pierre
et al. 2006; Adhihetty et al. 2009) and that lack of PGC-
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Figure 6. (A) PDP1 protein content, (B) PDK1 protein content, (C) PDK2 protein content, (D) PDK4 protein content in quadriceps muscle from
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1a furthermore leads to ROS accumulation (St-Pierre
et al. 2006; Olesen et al. 2013). ROS has been shown to
increase in mouse skeletal muscle with fasting (Qi et al.
2014; Rahman et al. 2014) and as SIRT3 has been shown
to play a role in ROS scavenging (Qiu et al. 2010; Yu
et al. 2012) increasing SIRT3 protein may be an adapta-
tion to handling a prolonged period of increased ROS
production. SIRT3 protein has previously been shown to
increase with fasting and caloric restriction in wild-type
mice (Palacios et al. 2009) and to increase with both
repeated AICAR injections and exercise training in a
PGC-1a-dependent manner using PGC-1a KO mice
(Brandauer et al. 2015). The present observation that
skeletal muscle SIRT3 protein was lower in PGC-1a
MKO mice than controls is therefore in accordance with
previous studies. However, the present finding that
SIRT3 protein content was completely unresponsive to
24 h of fasting in PGC-1a MKO mice is novel. Further-
more, the higher lysine acetylation level of PDH-E1a in
PGC-1a MKO mice than controls in the fed state is in
agreement with a previous study using myocytes (Jing
et al. 2013) and with the present genotype difference in
SIRT3 protein content. The lack of a genotype difference
in PDH-E1a acetylation in the fasted state indicates on
the other hand that PGC-1a-deficient mouse skeletal
muscle is capable of maintaining the PDH acetylation
state equal to control muscle despite reduced SIRT3 pro-
tein level. As muscle NAD+ levels have been shown to
increase with fasting (Canto et al. 2010), this may upreg-
ulate SIRT3 activity (Schwer et al. 2002) sufficiently in
PGC-1a MKO mice to obtain an acetylation state as in
control mice.
The present observation that 24 h of fasting led to
robust increases in absolute phosphorylation of all the
four PDH phosphorylation sites, PDHSer293, PDHSer300,
PDHSer232, and PDHSer295, in both genotypes is in line
with the downregulation of PDHa activity and the previ-
ously reported fasting effects in PGC-1a KO and PGC-1a
MCK mice (Kiilerich et al. 2010). On the other hand, the
fasting-induced increase in skeletal muscle PDHSer232
phosphorylation has not been reported previously. The
observed increase in PDH-E1a protein with fasting was
unexpected, but might be explained by a possible increase
in PGC-1a and thus mitochondrial content as previously
reported in liver (Haase et al. 2011) and skeletal muscle
(Palacios et al. 2009; Canto et al. 2010). However, the
lack of a similar increase in OXPHOS protein with fasting
in the present study (data not shown) does not support
this notion. Regardless, it appears that PGC-1a is partly
dispensable for fasting-induced increases in PDH-E1a
protein.
PDH phosphorylation levels were also normalized to
PDH-E1a protein content due to the impact of both
genotype and intervention on PDH-E1a protein content.
The observation that normalization of PDH phosphoryla-
tion to PDH-E1a protein resulted in similar or even
higher levels of PDH phosphorylation in PGC-1a MKO
than control mice indicates a maintained capability to
regulate PDH relative to the amount of PDH-E1a protein
despite lack of PGC-1a. Furthermore, the small genotype
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differences in both site PDHSer232 and PDHSer295 when
normalized to PDH-E1a protein may be due to the site-
specific affinity of the different PDK isoforms as previ-
ously reported (Korotchkina and Patel 2001; Patel and
Korotchkina 2001).
The finding that skeletal muscle PDK4 protein was
markedly increased with fasting is in agreement with
numerous previous studies in humans, rats, and mice
(Wu et al. 1999, 2001; Pilegaard et al. 2003; Spriet et al.
2004; Zhang et al. 2006; Kiilerich et al. 2010). Although
PDK4 protein levels were lower in PGC-1a MKO than
control mice both in the fed and the fasted state, the
same absolute increase in PDK4 protein was evident in
both genotypes underlining that skeletal muscle PGC-1a
plays a role in basal PDK4 expression, but is not neces-
sary for the observed fasting-induced upregulation of
PDK4 protein content. The finding that the protein con-
tent of PDP1, PDK1, and PDK2 were unaffected by fast-
ing is in accordance with previous studies (Spriet et al.
2004; Bienso et al. 2014), but the lower protein levels of
PDP1, PDK1, and PDK2 in PGC-1a MKO mice than
controls have not been reported previously. This observa-
tion, in conjunction with reduced skeletal muscle
OXPHOS and PDH-E1a content in PGC-1a MKO mice,
as also previously shown in PGC-1a KO mice (Kiilerich
et al. 2010), indicates a reduced capacity for regulation of
glucose oxidation. However, the present observation that
the PDHa activity did not differ between genotypes sug-
gests that additional factors influence PDHa activity. In
addition, the observation that the genotype differences in
RER were not reflected in differences in skeletal muscle
in vitro PDHa activity supports the previous findings that
there can be a dissociation between PDHa activity and
actual flux through the PDC (Constantin-Teodosiu et al.
2004).
Skeletal muscle AMPK phosphorylation has been
reported to increase in rodents with shorter fasting proto-
cols (De et al. 2006; Canto et al. 2010; Frier et al. 2011).
However, the present finding of no change in AMPK
phosphorylation indicates that AMPK does not exhibit
increased phosphorylation levels after 24 h of fasting as
reported previously in mice (Gonzalez et al. 2004) and
humans (Wijngaarden et al. 2014). It cannot be excluded
that the mice in the present study had transiently
increased AMPK activation during the fasting interven-
tion in the hours prior to euthanization, and that this
activation differed between genotypes, especially with dif-
fering locomotor activity in the light phase of both the
fed and fasting intervention. The observed increase in
phosphorylation of ACC with fasting likely contributing
to the enhanced fatty acid oxidation (FAO) might reflect
a preceding, transient activation of AMPK as previously
observed in rat skeletal muscle after 12 h of fasting, but
not 48 h of fasting (De et al. 2006). On the other hand,
ACC deactivation may also occur through a proposed
fasting-induced b-adrenergic epinephrine/PKA axis (Frier
et al. 2011). The finding that ACC phosphorylation was
higher in PGC-1a MKO mice than controls during fasting
when normalized to protein content may indicate fewer
active ACC proteins and hence less malonyl CoA to inhi-
bit lipid uptake into the mitochondria in PGC-1a MKO
than control mice. Furthermore, the observed similar FFA
plasma level in the two genotypes suggests a similar deliv-
ery of fatty acids to the muscles in the two genotypes.
These observations are therefore not in accordance with
the higher RER values indicating elevated CHO oxidation
in PGC-1a MKO mice than controls. However, both
CD36 mRNA and CPT1 mRNA content have been shown
to increase with fasting (Long et al. 2005; Frier et al.
2011) and to be PGC-1a dependent (Calvo et al. 2008)
suggesting that the mitochondrial fatty acid transport step
may limit fat oxidation during fasting in PGC-1a defi-
cient muscle and hence potentially explain the reduced fat
oxidation during fasting when PGC-1a is lacking.
In summary, the present study suggests that skeletal
muscle PGC-1a plays an important role in skeletal muscle
mitochondrial protein adaptations to prolonged fasting,
as seen with PDH-E1a and SIRT3, but is dispensable for
maintaining metabolic flexibility in the transition from
the fed to the fasted state. Furthermore, lack of skeletal
muscle PGC-1a reduces the content of PDH regulatory
proteins and PDH-E1a protein as well as alters PDH
phosphorylation and the acetylation pattern in skeletal
muscle. In addition, while both fed and fasting-induced
PDHa activities appear independent of PGC-1a, PGC-1a
is required for fasting-induced SIRT3 protein upregula-
tion in skeletal muscle.
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